ETTX Entasis Therapeutics Holdings

Entasis Therapeutics to Participate in the BMO 2020 Prescriptions for Success Healthcare Conference

Entasis Therapeutics to Participate in the BMO 2020 Prescriptions for Success Healthcare Conference

WALTHAM, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Officer of the Company, will participate in a fireside chat at the BMO 2020 Prescriptions for Success Healthcare Conference being held virtually on June 23, 2020.

Details of the fireside chat are below:

Event:  BMO 2020 Prescriptions for Success Healthcare Conference

Date:  Tuesday, June 23, 2020

Location:  

Time:  3:30 PM ET

Additionally, Dr. Perros will hold 1-on-1 virtual investor meetings at the conference. Investors attending the conference virtually who are interested in meeting with Company management should contact their BMO representatives.

About Entasis

Entasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis’ pathogen-targeted design platform has produced a pipeline of product candidates, including sulbactam-durlobactam (targeting Acinetobacter baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae infections), ETX0282CPDP (targeting Enterobacteriaceae infections) and ETX0462 (targeting Pseudomonas infections). For more information, visit .

Entasis Forward-looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on Entasis’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from these forward-looking statements. Many factors may cause differences between current expectations and actual results, including unexpected safety or efficacy data observed during non-clinical or clinical studies, clinical site activation rates or clinical trial enrollment rates that are lower than expected and changes in expected or existing competition, changes in the regulatory environment, failure of Entasis’ collaborators to support or advance collaborations or product candidates and unexpected litigation or other disputes. Many of these factors are beyond Entasis’ control. These and other risks and uncertainties are described more fully in the Entasis’ filings with the U.S. Securities and Exchange Commission, including the section titled “Risk Factors” contained therein. Forward-looking statements contained in this announcement are made as of this date, and except as required by law, Entasis assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

Entasis Company Contact    

Kyle Dow

Entasis Therapeutics

(781) 810-0114

Investor Relations Contacts

Tram Bui / James Salierno

The Ruth Group

(646) 536-7035 / 7028



Media Contact

Kirsten Thomas

The Ruth Group

(508) 280-6592

 

EN
18/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Entasis Therapeutics Holdings

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
INFY INFOSYS LIMITED
QRVO QORVO INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WEN WENDY'S COMPANY
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
UMH UMH PROPERTIES INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PCRX PACIRA BIOSCIENCES INC.
PANW PALO ALTO NETWORKS INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MXL MAXLINEAR INC
MU MICRON TECHNOLOGY INC.
MGNX MACROGENICS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
JACK JACK IN THE BOX INC.
INTC INTEL CORPORATION
IMAX IMAX CORPORATION
GME GAMESTOP CORP. CLASS A
GBT GLOBAL BLOOD THERAPEUTICS INC
FRC FIRST REPUBLIC BANK
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
DKS DICK'S SPORTING GOODS INC.
DECK DECKERS OUTDOOR CORPORATION
DBD DIEBOLD NIXDORF INCORPORATED
CXW CORECIVIC INC.
CTMX CYTOMX THERAPEUTICS INC.
CRM SALESFORCE.COM INC.
CMRX CHIMERIX INC
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
CFG CITIZENS FINANCIAL GROUP INC.
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BBY BEST BUY CO. INC.
AXTI AXT INC.
ATVI ACTIVISION BLIZZARD INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
SWKS SKYWORKS SOLUTIONS INC.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
PVH PVH CORP.
HPE HEWLETT PACKARD ENTERPRISE CO.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ALNA ALLENA PHARMACEUTICALS
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
TENB TENABLE HOLDINGS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
SCPL SCIPLAY
CRWD CROWDSTRIKE HOLDINGS INC. CLASS A
BCEL ATRECA
CHWY CHEWY INC. CLASS A
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
CRNC CERENCE
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
KDNY CHINOOK THERAPEUTICS
PASG INC.
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
ASO ADICET BIO INC
ITOS ACADEMY SPORTS AND OUTDOORS
ZNTL ITEOS THERAPEUTICS
U ZENTALIS PHARMACEUTICALS
TVTX UNITY SOFTWARE
SKLZ TRAVERE THERAPEUTICS INC
VRDN SKILLZ INC (A)
WOOF VIRIDIAN THERAPEUTICS INC
PLTK PETCO HEALTH AND WELLNESS
TSHA PLAYTIKA HOLDING
RBLX TAYSHA GENE THERAPIES
DAWN ROBLOX
CYT DAY ONE BIOPHARMACEUTICALS INC
ELEV CYTEIR THERAPEUTICS
OMGA INC
THRX ELEVATION ONCOLOGY
STX OMEGA THERAPEUTICS
IMPL THESEUS PHARMACEUTICALS
APP INC.
TCRR SEAGATE TECHNOLOGY HLDGS PLC
AVTE IMPEL NEUROPHARMA INC
GFS APPLOVIN CORP
WEJO TCR2 THERAPEUTICS INC
KRTX AEROVATE THERAPEUTICS INC
FUSN GLOBALFOUNDRIES INC
EWTX WEJO GROUP LTD
KARUNA THERAPEUTICS INC
FUSION PHARMACEUTICALS INC
EDGEWISE THERAPEUTICS INC
Andreas Argyrides ... (+7)
  • Andreas Argyrides
  • David Nierengarten
  • Dennis Pak
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Sam Ravina
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PCRX PACIRA BIOSCIENCES INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MGNX MACROGENICS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
GBT GLOBAL BLOOD THERAPEUTICS INC
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ARDX ARDELYX INC
FRX_CN FENNEC PHARMACEUTICALS
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ALNA ALLENA PHARMACEUTICALS
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
BCEL ATRECA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
KDNY CHINOOK THERAPEUTICS
PASG INC.
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
ITOS ADICET BIO INC
ZNTL ITEOS THERAPEUTICS
TVTX ZENTALIS PHARMACEUTICALS
VRDN TRAVERE THERAPEUTICS INC
TSHA VIRIDIAN THERAPEUTICS INC
DAWN TAYSHA GENE THERAPIES
CYT DAY ONE BIOPHARMACEUTICALS INC
ELEV CYTEIR THERAPEUTICS
OMGA INC
THRX ELEVATION ONCOLOGY
IMPL OMEGA THERAPEUTICS
TCRR THESEUS PHARMACEUTICALS
AVTE INC.
KRTX IMPEL NEUROPHARMA INC
FUSN TCR2 THERAPEUTICS INC
EWTX AEROVATE THERAPEUTICS INC
KARUNA THERAPEUTICS INC
FUSION PHARMACEUTICALS INC
EDGEWISE THERAPEUTICS INC
Andreas Argyrides ... (+7)
  • Andreas Argyrides
  • David Nierengarten
  • Dennis Pak
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Sam Ravina
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PCRX PACIRA BIOSCIENCES INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MGNX MACROGENICS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
GBT GLOBAL BLOOD THERAPEUTICS INC
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ARDX ARDELYX INC
FRX_CN FENNEC PHARMACEUTICALS
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ALNA ALLENA PHARMACEUTICALS
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
BCEL ATRECA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
KDNY CHINOOK THERAPEUTICS
PASG INC.
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
ITOS ADICET BIO INC
ZNTL ITEOS THERAPEUTICS
TVTX ZENTALIS PHARMACEUTICALS
VRDN TRAVERE THERAPEUTICS INC
TSHA VIRIDIAN THERAPEUTICS INC
DAWN TAYSHA GENE THERAPIES
CYT DAY ONE BIOPHARMACEUTICALS INC
ELEV CYTEIR THERAPEUTICS
OMGA INC
THRX ELEVATION ONCOLOGY
IMPL OMEGA THERAPEUTICS
TCRR THESEUS PHARMACEUTICALS
AVTE INC.
KRTX IMPEL NEUROPHARMA INC
FUSN TCR2 THERAPEUTICS INC
EWTX AEROVATE THERAPEUTICS INC
KARUNA THERAPEUTICS INC
FUSION PHARMACEUTICALS INC
EDGEWISE THERAPEUTICS INC
 PRESS RELEASE

Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces...

Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022 Six abstracts selected for presentation, including three oral presentations WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- , a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, and wholly owned subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that six abstracts highlighting sulbactam-durlobactam (SUL-DUR) have been selected for presentation at , the annual meeting of the Infectious Disea...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SGMO SANGAMO THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PZZA PAPA JOHN'S INTERNATIONAL INC.
PCRX PACIRA BIOSCIENCES INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MGNX MACROGENICS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
GME GAMESTOP CORP. CLASS A
GBT GLOBAL BLOOD THERAPEUTICS INC
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ATVI ACTIVISION BLIZZARD INC.
ARDX ARDELYX INC
NFLX NETFLIX INC.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
VRNA VERONA PHARMA ADS
ALNA ALLENA PHARMACEUTICALS
AMZN AMAZON.COM INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
SCPL SCIPLAY
BCEL ATRECA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
KDNY CHINOOK THERAPEUTICS
PASG INC.
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
ITOS ADICET BIO INC
ZNTL ITEOS THERAPEUTICS
U ZENTALIS PHARMACEUTICALS
TVTX UNITY SOFTWARE
SKLZ TRAVERE THERAPEUTICS INC
VRDN SKILLZ INC (A)
PLTK VIRIDIAN THERAPEUTICS INC
TSHA PLAYTIKA HOLDING
RBLX TAYSHA GENE THERAPIES
DAWN ROBLOX
CYT DAY ONE BIOPHARMACEUTICALS INC
ELEV CYTEIR THERAPEUTICS
IS INC
UPST ELEVATION ONCOLOGY
OMGA IRONSOURCE
THRX UPSTART HOLDINGS
IMPL OMEGA THERAPEUTICS
TCRR THESEUS PHARMACEUTICALS
AVTE INC.
KRTX IMPEL NEUROPHARMA INC
FUSN TCR2 THERAPEUTICS INC
EWTX AEROVATE THERAPEUTICS INC
KARUNA THERAPEUTICS INC
FUSION PHARMACEUTICALS INC
EDGEWISE THERAPEUTICS INC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch